Skip to content

Skip to secondary menu

Jehovah’s Witnesses


Neonatal Medicine

Hyperbilirubinemia Management

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia.

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ

Source‎: J Perinatol 2016;36(7):533-9.

Indexed‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Source‎: Cochrane Database Syst Rev 2012;12:CD009017.

Indexed‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

Dose-response relationship of phototherapy for hyperbilirubinemia.

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Source‎: Pediatrics 2012;130(2):e352-7.

Indexed‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study.

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Source‎: J Perinatol 2013;33(2):126-33.

Indexed‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.

Okwundu CI, Okoromah CA, Shah PS.

Source‎: Cochrane Database Syst Rev 2012;1:CD007966.

Indexed‎: PubMed 22258977

DOI‎: 10.1002/14651858

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation.

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Source‎: Pediatrics 2011;128(4):e1046-52.

Indexed‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia.

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Source‎: Acta Paediatr 2011;100(4):620-3.

Indexed‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia.

Mehta S, Kumar P, Narang A.

Source‎: J Pediatr 2005;147(6):781-5.

Indexed‎: PubMed 16356431

Sn-mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.

Kappas A, Drummond GS, Munson DP, Marshall JR.

Source‎: Pediatrics 2001;108(6):1374-7.

Indexed‎: PubMed 11731664

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.